PKM and cancer: The critical regulators of the glycolytic pathway, HK-II, PKM2, and HIF-1α that contribute to the metabolic reprogramming in cancer cells (25–27) also showed a profound increase in the OPM-BMG cells in comparison to BMG-1 cells (Figure 1E).